Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2013-12-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Surgical Pleth Index in Guiding Anesthesia in Gastroenterological Surgery
NCT04519203
Evaluation of the Surgical Pleth Index During Spinal and General Anesthesia
NCT00789438
Surgical Pleth Index: Predicting the Optimal Timing for Tracheal Intubation During General Anesthesia
NCT04608240
The Effect of SPI (Surgical Pleth Index) - Guided Anaesthesia on Opioid Consumption in Gastric Sleeve Surgery
NCT05884229
Comparison of the Surgical Pleth Index and the Nociception Level Index in the Pediatric Population
NCT07084935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
The control group of three sites for larger Adequacy of Anaesthesia study. Total 150 patients
Control group
A group of no Monitoring patients from larger AoA study with no adequacy of anaesthesia monitoring
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control group
A group of no Monitoring patients from larger AoA study with no adequacy of anaesthesia monitoring
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-80 years of age
* Surgery that is expected to last at least 2 hours under general anesthesia with endotracheal tube
Exclusion Criteria
* Any subject with a cardiac pacemaker
* Any subject with atrial fibrillation at the time of obtaining the baseline values
* Any subject with more than 5 ventricular extra systoles/minute at the time of obtaining the baseline values
* Any subject who needs invasive blood pressure measurement
* Any subject who show hemodynamics that would have qualified for being considered as a sign of inadequate anesthesia already at baseline:
o Mean blood pressure below 60 mmHg or above 100 mmHg o HR below 45 /min or above 100/min
* Any subject with epidural anesthesia or analgesia during the surgery. Epidural catheter may be placed pre-operatively, and used in the PACU, but not during the surgery
* Any subject having surgery that requires prone position
* Any subject with very high body mass index (\>35) because of incompatibility with the target controlled anesthesia models used
* Any subject with known allergies to the specific anesthetic agents/ analgesic drugs intended for use in their surgeries
* Any subject with laryngeal mask airway
* Any subject who requires neuromuscular blocking agent infusion
* Any subject who is going to have major surgery with a high risk of extensive blood loss
* Any subject with known chronic use of opioids
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jarkko Harju, MD
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tampere University Hospital
Tampere, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JH2013-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.